Jung, Min J.
Kanegi, Skyler L.
Rosen, Noah L.
Article History
Accepted: 30 November 2023
First Online: 14 December 2023
Compliance with Ethical Standards
:
: M. Jung — No disclosures. S.L. Kanegi — No disclosures. N.L. Rosen — Dr. Rosen is on the speaker panel for Abbvie, has participated in advisory boards for Abbvie/Allergan, Eli Lilly, Impel, Lundbeck, Biohaven, and Pfizer, and has had research support from Amgen, Pfizer, Curelator, and Eli Lilly. He is a section editor for Current Pain and Headache Reports and sits on the board of the American Headache Society.
: This article does not contain any studies with human or animal subjects performed by any of the authors.